PT-141 (Bremelanotide) is a cyclic heptapeptide and melanocortin receptor agonist derived from α-MSH. It has been characterized in the research literature for studies in central-nervous-system-mediated research applications. Nova supplies PT-141 in a 10mg lyophilized vial that requires reconstitution with a suitable solvent before research use. A pre-mixed air dispersal research spray format (PT-141 Spray) is available separately. Every batch is triple-tested by an independent, ISO/IEC 17025-accredited laboratory. Every vial ships with a QR code linked to its batch Certificate of Analysis. For research use only. Not for human or animal consumption.
